abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기사

2009년 11월 2일

저자:
Brent Kendall, Dow Jones

US High Court Asks Administration To Comment On Nigeria Drug Trial Case

The U.S. Supreme Court on Monday asked the Obama administration's solicitor general to weigh in on Pfizer Inc.'s (PFE) challenge to a pair of lawsuits alleging the drug maker illegally tested an antibiotic drug on children in Nigeria in 1996. Two groups of Nigerian families alleged that Pfizer violated international law when it tested the experimental drug Trovan on 200 Nigerian children during an outbreak of bacterial meningitis... Pfizer said the study, conducted in the Nigerian state of Kano, took place with the approval of the Nigerian government and the consent of the children's parents.

타임라인